In this month's episode, we discuss the shifting treatment of ovarian cancer in Australia, including the diagnostics testing changes concerning HRD, and the implications for nurses in monitoring and managing patients.
CNSA is proud to present this webinar in collaboration with our national partner, Eisai, focused on the latest treatment strategies for advanced endometrial cancer treated with Lenvima in combination pembrolizumab and discuss what we have learnt so far.
